Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Takuro Nakamura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0419-7547; OpenAlex author ID A5016375050. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer Xenograft Model Co-author DOI 10.20944/preprints202609.1232.v1↗
  2. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer. Co-author DOI 10.1089/mab.2017.0050↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yukinari Kato · 2 shared papers, 2017–2026 · strength 0.46
  2. Mika Kato Kaneko · 2 shared papers, 2017–2026 · strength 0.46
  3. Hiroyuki Suzuki · 1 shared paper, 2026 · strength 0.39
  4. Shinji Yamada · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.